DePuy Synthes Exceeds Expectations in the First Quarter

DePuy Synthes' logo

DePuy Synthes reported 1Q21 orthopedic revenue of USD $2,113.5 million, +3.7% vs. 1Q20. Compared to 1Q19, sales for the quarter declined -4.1%.

Still, the company performed better than expected, given the record-breaking COVID surge that opened the year. Leadership attributed the growth to improved execution and new products along with...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us